Illicit Stimulant Use in a United States Heart Failure Population Presenting to the Emergency Department (from the Acute Decompensated Heart Failure National Registry Emergency Module)

American Journal of Cardiology

Volumn 102, Issue 9, 2008, Pages 1216-1219

  Diercks, Deborah B ^a   Fonarow, Gregg C ^b   Kirk, J Douglas ^a   Jois Bilowich, Preeti ^c   Hollander, Judd E ^d   Weber, Jim Edward ^e,f   Wynne, Janet ^g   Mills, Roger M ^g   Yancy, Clyde ^h   Peacock IV, W Franklin ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f HURLEY MEDICAL CENTER   (United States)

^g SCIOS INC   (United States)

^h BAYLOR UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CENTRAL STIMULANT AGENT; COCAINE; ILLICIT DRUG; METHAMPHETAMINE;

ACUTE HEART FAILURE; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG USE; EMERGENCY WARD; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; REGISTER; SELF REPORT; UNITED STATES; UREA NITROGEN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STREET DRUGS; UNITED STATES;

EID: 54549105729     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.06.045     Document Type: Article

References (24)

1. DAWN Series D-29. Drug Abuse Warning Network, 2005: National Estimates of Drug-Related Emergency Department Visits. DHHS Publication No. (SMA) 07-4256 (2007), United States Department of Health and Human Services, Rockville, Maryland 114-117
2. Chakko S., Fernandez A., Mellman T.A., Milanes F.J., Kessler K.M., and Myerburg R.J. Cardiac manifestations of cocaine abuse: a cross-sectional study of asymptomatic men with a history of long-term abuse of "crack" cocaine. J Am Coll Cardiol 20 (1992) 1168-1174
3. Hong R., Matsuyama E., and Nur K. Cardiomyopathy associated with the smoking of crystal methamphetamine. JAMA 265 (1991) 1152-1154
4. Chakko S., and Myerburg R.J. Cardiac complications of cocaine abuse. Clin Cardiol 18 (1995) 67-72
5. Arzola-Castaner D., and Johnson C. Cocaine-induced myocardial infarction associated with severe reversible systolic dysfunction and pulmonary edema. P R Health Sci J 23 (2004) 319-322
6. Besse S., Assayag P., Latour C., Janmot C., Robert V., Delcayre C., Nahas G., and Swynghedauw B. Molecular characteristics of cocaine-induced cardiomyopathy in rats. Eur J Pharmacol 338 (1997) 123-129
7. Karch S.B., and Billingham M.E. The pathology and etiology of cocaine-induced heart disease. Arch Pathol Lab Med 112 (1988) 225-230
8. Mehta P.M., Grainger T.A., Lust R.M., Movahed A., Terry J., Gilliland M.G., and Jolly S.R. Effect of cocaine on left ventricular function. Relation to increased wall stress and persistence after treatment. Circulation 91 (1995) 3002-3009
9. Robledo-Carmona J., Ortega-Jimenez M.V., Garcia-Pinilla J.M., Cabra B., and de Teresa E. Severe cardiomyopathy associated to cocaine abuse. Int J Cardiol 112 (2006) 130-131
10. Om A., Ellahham S., and Ornato J.P. Reversibility of cocaine-induced cardiomyopathy. Am Heart J 124 (1992) 1639-1641
11. Cheng T.O. Cocaine and chronic cardiomyopathy. Hosp Pract (Off Ed) 26 (1991) 9
12. Wiener R.S., Lockhart J.T., and Schwartz R.G. Dilated cardiomyopathy and cocaine abuse. Report of two cases. Am J Med 81 (1986) 699-701
13. Wijetunga M., Seto T., Lindsay J., and Schatz I. Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?. J Toxicol Clin Toxicol 41 (2003) 981-986
14. Jacobs L.J. Reversible dilated cardiomyopathy induced by methamphetamine. Clin Cardiol 12 (1989) 725-727
15. Yeo K.K., Wijetunga M., Ito H., Efird J.T., Tay K., Seto T.B., Alimineti K., Kimata C., and Schatz I.J. The association of methamphetamine use and cardiomyopathy in young patients. Am J Med 120 (2007) 165-171
16. Singer A.J., Emerman C., Char D.M., Heywood J.T., Kirk J.D., Hollander J.E., Summers R., Lee C.C., Wynne J., Kellerman L., and Peacock W.F. Bronchodilator therapy in acute decompensated heart failure patients without a history of chronic obstructive pulmonary disease. Ann Emerg Med 51 (2008) 25-34
17. Fonarow G.C., Adams Jr. K.F., Abraham W.T., Yancy C.W., and Boscardin W.J. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293 (2005) 572-580
18. Hebert K.A., Horswell R.L., Dy S., Key Jr. I.J., Butler M.K., Cerise F.P., and Arcement L.M. Mortality benefit of a comprehensive heart failure disease management program in indigent patients. Am Heart J 151 (2006) 478-483
19. Rauh R.A., Schwabauer N.J., Enger E.L., and Moran J.F. A community hospital-based congestive heart failure program: impact on length of stay, admission and readmission rates, and cost. Am J Manag Care 5 (1999) 37-43
20. Lattanzio Jr. F.A., Tiangco D., Osgood C., Beebe S., Kerry J., and Hargrave B.Y. Cocaine increases intracellular calcium and reactive oxygen species, depolarizes mitochondria, and activates genes associated with heart failure and remodeling. Cardiovasc Toxicol 5 (2005) 377-390
21. Patel M.M., Belson M.G., Wright D., Lu H., Heninger M., and Miller M.A. Methylenedioxymethamphetamine (ecstasy)-related myocardial hypertrophy: an autopsy study. Resuscitation 66 (2005) 197-202
22. Newton T.F., De La Garza II R., Kalechstein A.D., and Nestor L. Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects. Pharmacol Biochem Behav 82 (2005) 90-97
23. Wilson L.D., Henning R.J., Suttheimer C., Lavins E., Balraj E., and Earl S. Cocaethylene causes dose-dependent reductions in cardiac function in anesthetized dogs. J Cardiovasc Pharmacol 26 (1995) 965-973
24. Frishman W.H., Del Vecchio A., Sanal S., and Ismail A. Cardiovascular manifestations of substance abuse part 1: cocaine. Heart Dis 5 (2003) 187-201